IGC Pharma (IGC) SEC Filings & 10K Form $0.36 0.00 (0.00%) (As of 09/13/2024 ET) Add Compare Share Share SEC FilingsStock AnalysisAnalyst ForecastsChartFinancialsSEC FilingsStock AnalysisAnalyst ForecastsChartFinancialsSEC Filings Recent IGC Pharma SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView08/14/20243:23 PMBradbury Strategic Investment Fund A (0002022777) (Filed by)IGC Pharma (Subject)Form SC 13D/A08/12/20248:26 AMIGC Pharma (Issuer)PRINS RICHARD K (Reporting)Form 4Statement of changes in beneficial ownership of securities 08/09/20245:03 PMIGC Pharma (Subject)PRINS RICHARD K (Reporting)Form 144Notice of proposed sale of securities pursuant to Rule 144 08/02/20241:38 PMIGC Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/09/20241:17 PMIGC Pharma (Filer)Form DEFA14A06/24/202412:32 PMIGC Pharma (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 05/21/20248:20 PMBradbury Strategic Investment Fund A (0002022777) (Filed by)IGC Pharma (Subject)Form SC 13D05/13/20248:53 PMBradbury Strategic Investment Fund A (0002022777) (Reporting)IGC Pharma (Issuer)Form 3Initial statement of beneficial ownership of securities 05/13/20248:54 PMBradbury Strategic Investment Fund A (0002022777) (Reporting)IGC Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 05/02/202411:15 PMIGC Pharma (Filer)Form EFFECT04/05/202410:33 AMIGC Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/15/20248:27 PMGRIMALDI CLAUDIA (Reporting)IGC Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 03/15/20248:05 PMIGC Pharma (Issuer)Moran James P (Reporting)Form 4Statement of changes in beneficial ownership of securities 03/15/20248:09 PMIGC Pharma (Issuer)PRINS RICHARD K (Reporting)Form 4Statement of changes in beneficial ownership of securities 03/15/20247:32 PMIGC Pharma (Subject)MUKUNDA RAM (Reporting)Form 144Notice of proposed sale of securities pursuant to Rule 144 03/15/20244:34 PMIGC Pharma (Issuer)LIERMAN TERRY L (Reporting)Form 4Statement of changes in beneficial ownership of securities 03/13/20248:00 AMIGC Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/12/20244:09 PMIGC Pharma (Issuer)LIERMAN TERRY L (Reporting)Form 3Initial statement of beneficial ownership of securities 01/08/202411:15 PMIGC Pharma (Filer)Form EFFECT11/09/20234:15 PMIGC Pharma (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 10/27/20234:21 PMIGC Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/27/20233:38 PMIGC Pharma (Filer)Form 424B510/05/202311:15 PMIGC Pharma (Filer)Form EFFECT09/29/20234:23 PMIGC Pharma (Filer)Form S-3Registration statement under Securities Act of 1933 (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies: Anixa Biosciences SEC Filings Journey Medical SEC Filings Regulus Therapeutics SEC Filings Checkpoint Therapeutics SEC Filings Incannex Healthcare SEC Filings Werewolf Therapeutics SEC Filings Oramed Pharmaceuticals SEC Filings Coya Therapeutics SEC Filings Renovaro SEC Filings CytomX Therapeutics SEC Filings SEC Filings Tools: Latest SEC FilingsInsider Trading Activity This page (NYSEMKT:IGC) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredIntroducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. Th...Brownstone Research | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia needs these 3 companies on a new $1 trillion SuperprojectNvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And i...Weiss Ratings | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGC Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IGC Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
